NCT02009410 - A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2 | Biotech Hunter

Timeline

Start Date

November 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2

Interventions

DRUG

Creon

Creon 25000 (2 capsules per meal 3 times per day and 1 capsule/snack 2 times per day) during 12 weeks

DRUG

Creon 25000 matching Placebo

Creon 25000 placebo matching capsules (2 capsules per meal 3 times per day and 1 capsule/snack 2 times per day) during 12 weeks

Trial Locations (10)

Site reference no. 112495, Santiago de Compostela

Site reference no. 112519, Madrid

Site reference no. 112520, Málaga

Site reference no. 113476, Pohlheim

Site reference no. 112518, Segovia

Site reference no. 112496, Seville

Site reference no. 113456, Bochum

Site reference no. 113477, Frankfurt

Site reference no. 113475, Ulm

Site reference no. 112517, Ávila